Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura

To the Editor: Scully et al. (Jan. 24 issue) 1 reported that in the HERCULES trial (A Phase III Double-Blind, Randomized, Parallel Group, Multicenter Placebo-Controlled Trial to Study the Efficacy and Safety of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura), caplacizumab...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The New England journal of medicine 2019-05, Vol.380 (18), p.e32-e32
Hauptverfasser:	Yang, Zhao, McCaw, Zachary R, Yin, Guosheng, Olson, Sven R, Samuelson-Bannow, Bethany T, Scully, Marie, Minkue Mi Edou, Jessica, Callewaert, Filip
Format:	Artikel
Sprache:	eng
Schlagworte:	ADAMTS13 Protein Humans Platelets Purpura, Thrombotic Thrombocytopenic Single-Domain Antibodies Thrombotic thrombocytopenic purpura
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!